Page 4 - Wockhardt

Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US

Glenmark said its current portfolio consists of 175 products authorised for distribution in the US market and 48 ANDAs pending approval with the USFDA

Wockhardt Q4 loss widens to Rs 311 crore even as income rises marginally

Pharmaceuticals firm Wockhardt Ltd on Monday reported widening of consolidated net loss to Rs 311 crore in the fourth quarter ended March 31, 2022.

Wockhardt, Serum Institute of India tie up to make vaccines in UK

SII has supplied the AstraZeneca-Oxford vaccine to the UK already, and having a fill-and-finish facility in the UK would help the firm to have closer access to the UK and EU markets.

Sensex sinks 769 pts, Nifty below 16,250; Titan, Maruti fall 5%, IT stks up

CLOSING BELL: Sectorally, only the Nifty IT index eked out gain on the NSE, rising 0.14 per cent

Stocks to Watch: Voda Idea, Wockhardt, KEC Intl, Tata Motors, Pharma, PSBs

Pharma shares are likely to be in limelight as NPPA may allow up to 10 per cent hike on scheduled drugs in the month of April.

Wockhardt sets issue price at Rs 225/share for Rs 748-cr rights issue

Earlier in January this year, Wockhardt's board had approved raising of up to Rs 1,000 crore through a rights issue to its existing shareholders

Wockhardt gets CDSCO approval to export Russian Covid vaccine Sputnik

The approval is for the export of up to 8 crore doses of Sputnik Light and up to 2 crore doses of Sputnik V Component I vaccines, Wockhardt Ltd said in a regulatory filing

Sensex slips 581 pts amid hawkish US Fed, F&O expiry; Nifty holds 17,100

Sectorally, the Nifty PSU Bank index jumped a massive 5 per cent on the NSE, while the Nifty Bank and Private Bank indices added about a per cent each

Wockhardt reports consolidated net profit of Rs 1.77 cr in Q3

Drug maker Wockhardt on Thursday reported a consolidated net profit of Rs 1.77 crore for the third quarter of 2021

Stocks to Watch: RIL, Wockhardt, IDBI Bk, SJVN, Titan, DMart, FMCG, Pharma

Pharma shares may be in focus as India's apex health research organization ICMR has raised concerns around the safety for use of the oral antiviral drug Molnupiravir

Wockhardt board approves plan to raise Rs 1,000 crore via rights issue

Pharmaceuticals firm Wockhardt Ltd said its board has approved a proposal to raise up to Rs 1,000 crore through a rights issue.

RIL, HDFC, TCS power 673-pts rally in Sensex; Nifty tops 17,800; banks soar

The broader markets underperformed the benchmarks by a wide margin. The BSE MidCap and SmallCap indices ended with meagre gains of 0.05 per cent and 0.4 per cent, respectively.

Stocks to Watch: RIL, Tata Motors, Maruti, NCC, Marico, Hind Zinc, IT stks

Auto majors Maruti and Tata Motors are likely to be in focus today, the former for registering highest exports in a calendar year, and the latter for becoming the second largest PV seller in India.

Wockhardt Q2 net profit zooms over 11-fold to Rs 37.17 crore

Drug firm Wockhardt on Monday reported an over 11-fold jump in its consolidated net profit to Rs 37.17 crore for the quarter ended September 30, 2021.

Stocks to Watch: Aurobindo, Divi's, PTC, Sun Tv, Muthoot Fin, realty shares

Realty stocks on the back of PAG taking a contra call on the sector and corporate earnings will be in focus today

Wockhardt signs pact with Russian co to make 620 mn Sputnik doses in 2 yrs

This is twice the amount of doses Serum Institute of will make of the Russian shot, will take total Sputnik V capacity in India to 1.7 bn doses a year

Wockhardt's growth tonic: Covid vaccines add a third prong to biz strategy

In India, Wockhardt aims to make 2 billion doses of Covid-19 vaccines within the next one or two years but has not disclosed the identity of the tie-ups

Wockhardt plans tie-ups for next-gen Covid-19 vax, aims to make 2 bn doses

Company aims to make 2 billion doses of vaccines in 1 to 2 years

These 20 small-cap stocks appear overbought on the charts. Trade cautiously

Out of these 20 counters, only 4 stocks are showing weakness in the overbought condition and can correct in the days ahead.

Wockhardt's Covid vaccine supply deal with UK Govt extended for 6 months

The drug firm said it has been awarded a six-month extension of its agreement with the UK government